Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
AstraZeneca Pharma India Limited has informed the Exchange about Closure of Trading Windowmore...
AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tra...more...
AstraZeneca Pharmaceuticals AB has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi...more...
ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/...more...
Please find the enclosed intimation of the Company in relation to the captioned subject for the appointment of Managing Director.more...
Please find the enclosed intimation of the Company in relation to the captioned subject for reference.more...
AstraZeneca Pharma India Limited has informed the Exchange regarding Appointment of Mr. Praveen Rao Akkinepally as Managing Director of the company w...more...
AstraZeneca Pharma India Limited has informed the Exchange regarding Cessation of Dr. Sanjeev Kumar Panchal as Managing Director of the comp...more...
AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...
AstraZeneca Pharma India Limited has informed the Exchange about Copy of Newspaper Publicationmore...
ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 30-May-2025 for Dividendmore...
ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Tr...more...
The company reported standalone net profit of Rs 58.25 crore for the quarter ended March 31 2025 as compared to Rs 39.48 crore in the same p...more...
Please find the enclosed press release of the Company in relation to the financial results.more...
AstraZeneca Pharma India Limited has informed the Exchange regarding Press Release .more...
AstraZeneca Pharma India Limited has submitted to the Exchange the financial results for the period ended March 31 2025.more...
Please find the enclosed financial results for your reference.more...
AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on May 30 2025.more...
Enter Stock
BOARD MEETINGS Company Name : Kuberan Global Edu Date : 24-06-2025